Common cancers in cats: lymphoma, oral carcinoma, and other prevalent tumors

How many cat owners know that intestinal lymphoma is now the most frequently diagnosed cancer in feline practice? The number is counterintuitive. For decades, mediastinal lymphoma tied to feline leukemia virus (FeLV) sat at the center of the feline oncology picture, especially in young cats. Widespread vaccination, serologic screening, and responsible adoption programs reshaped the map. The veterinary oncologist now faces, more than anything, a twelve- or fourteen-year-old cat with intermittent vomiting, weight loss, and a thickened loop of bowel on ultrasound, not a FeLV-positive kitten with a chest mass.

David Vail, across successive editions of the reference text Withrow & MacEwen's Small Animal Clinical Oncology, places lymphoma at around 30 percent of all feline neoplasms recorded in large case series. Kessler (2013), in the Journal of Feline Medicine and Surgery, reached similar figures in Europe. The overall cancer incidence in cats runs somewhat below that of dogs, but the biological aggressiveness of certain feline tumors more than offsets that gap and demands a different approach than the one general culture associates with "pet cancer."

Feline lymphoma: the dominant oncologic disease

Lymphoma represents between 25 and 35 percent of all tumors diagnosed in cats, depending on the series. Its clinical behavior depends heavily on anatomic location.

Gastrointestinal lymphoma

The most common form in cats today, particularly in those over ten years old. It splits into two grades:

• Small-cell lymphoma (low-grade, intermediate). Indolent course, diffuse infiltration of the intestinal mucosa, chronic vomiting, small-bowel diarrhea, progressive weight loss. Clinically indistinguishable from inflammatory bowel disease (IBD); telling them apart requires biopsy, immunohistochemistry, and sometimes PCR clonality testing. Prognosis is relatively good with oral chlorambucil and prednisolone, with median survival of 18 to 24 months and frequent sustained responses.
• Large-cell lymphoma (high-grade). Aggressive behavior, a palpable mass or severe focal thickening, marked systemic signs. Treated with multidrug chemotherapy on modified CHOP protocols. Median survival is 6 to 9 months with treatment, weeks without it.

The chronic presentation of small-cell lymphoma is easily confused with triaditis and IBD. That is why any adult cat with a chronic digestive picture deserves a workup that does not stop at "irritable gut."

Mediastinal lymphoma

Historically the lymphoma of the young, FeLV-positive cat. It is now a minority of cases thanks to vaccination, but it still appears in colonies without health management, in rescued kittens that were never screened, and in breeds such as the Siamese and Oriental, where a breed predisposition exists (FeLV-positive or not). Presentation: dyspnea, pleural effusion, orthopnea, regurgitation from esophageal compression. Prognosis is guarded even with chemotherapy.

Renal lymphoma

One of the causes of acute azotemia in the adult cat that goes unnoticed until the kidney is visibly nodular on ultrasound. It tends toward bilateral infiltration. It can coexist with central nervous system lymphoma, which darkens the prognosis considerably.

Nasal lymphoma

The most common tumor of the feline nasal cavity. Chronic sneezing, unilateral epistaxis that progresses to bilateral, deformity of the nasal bridge in advanced stages. It is highly radiosensitive, and radiation therapy (where available) produces durable responses. Median survival with radiation runs roughly 12 to 18 months, against 3 to 6 months with medical management alone.

Other locations

Cutaneous, ocular, cardiac, hepatic. Any lymphoid tissue, or tissue with resident lymphocytes, can harbor lymphoma. Immunohistochemistry (CD3, CD79a, CD20, Ki-67) refines the subtype and guides treatment.

Oral squamous cell carcinoma

The most aggressive malignant tumor diagnosed with any frequency in cats. It accounts for roughly 70 to 80 percent of feline oral tumors and shows up mostly in cats over ten years old.

Clinical presentation

• Halitosis that is marked and has no clear dental cause.
• Drooling, sometimes blood-tinged.
• Difficulty eating, progressive loss of appetite, weight loss.
• A visible mass on the tongue, floor of the mouth, gums, or palate.
• Abnormal tooth mobility without proportionate periodontal disease.
• In advanced mandibular tumors: facial deformity, skin ulceration.

Documented risk factors

Epidemiologic studies in the US veterinary literature (Bertone et al., 2003, among others) have linked feline oral and lymphoid cancers with:

• Environmental tobacco smoke in the home (relative risk 2 to 4 times higher).
• Prolonged use of flea collars in contact with the skin (a debated association).
• An exclusive diet of canned wet food over years (a minor factor).

Prognosis

Here is the bad news. Oral squamous cell carcinoma carries a guarded to poor prognosis in cats. Median survival without aggressive treatment is 1 to 3 months after diagnosis. With radical surgery (mandibulectomy or maxillectomy), radiation, and intensive nutritional support, series improve to 6 to 12 months, but with functional consequences that many owners will not accept.

Very early detection is the only route to durable responses. Any senior cat with new halitosis, drooling, or a change in how it eats deserves a careful oral exam under sedation.

Feline mammary tumors: why the 90 percent figure matters

In the female dog, roughly 50 percent of mammary tumors are malignant. In the queen, the number climbs to 85 to 90 percent. That difference carries enormous practical weight.

Biological behavior

• Mammary carcinoma in cats, most often tubular or solid type. Highly aggressive behavior.
• Frequent metastasis to regional lymph nodes, lung, and pleura.
• Local recurrence is common when surgery is not wide enough.

Treatment

The surgical indication is radical mastectomy, unilateral or staged bilateral, with removal of inguinal and axillary lymph nodes. Adjuvant chemotherapy (doxorubicin, carboplatin) is added for large tumors, nodal involvement, or close margins.

Prevention: early spaying genuinely counts

Studies by Overley et al. (2005) and later work showed that ovariohysterectomy before one year of age reduces the risk of feline mammary tumors by 86 to 91 percent. Spaying after two years loses much of the protective effect. For a cat expected to live 15 years, that figure alone justifies early spaying, setting aside the other benefits (population control, fewer escape attempts, pyometra prevention).

Feline injection-site sarcoma (FISS)

An entity unique to feline oncology. A soft-tissue sarcoma (fibrosarcoma, myofibroblastoma, malignant fibrous histiocytoma) that arises at a site where a vaccine or other injection was previously given. Estimated incidence runs roughly 1 to 10 cases per 10,000 vaccines administered, with US data trending toward the higher end.

Vaccines implicated

• Adjuvanted vaccines (traditional rabies, adjuvanted FeLV). The aluminum adjuvant is considered the principal driver of chronic inflammation.
• Cases have also been described with non-adjuvanted vaccines and even with injectable drugs.

The 3-2-1 rule

The American Association of Feline Practitioners (AAFP) and the World Small Animal Veterinary Association (WSAVA) recommend immediate biopsy if a mass is palpated at an injection site and it:

• Persists 3 months after vaccination.
• Measures 2 cm (about 0.8 inch) or more.
• Grows in size within 1 month.

Any one of the three conditions mandates incisional biopsy, not fine-needle aspiration, which yields false negatives.

Treatment

Surgery with very wide margins (5 cm, about 2 inches, laterally and two fascial planes deep). Without those margins, local recurrence exceeds 60 percent. Combined with adjuvant radiation at referral centers, survival improves substantially. Modern protocols recommend vaccinating in the distal tail or distal hind limbs, away from the interscapular region, so that amputation remains an option if FISS develops.

Other tumors worth knowing

Transitional cell carcinoma of the bladder

Less common than in dogs, but it occurs. Persistent hematuria, dysuria, a visible mass on bladder ultrasound. Surgery is complicated by the usual trigonal location.

Liver tumors

Hepatocellular adenoma and carcinoma, cholangiocarcinoma. Diagnosed by ultrasound and cytology or biopsy. Some resectable surgical cases carry an acceptable prognosis.

Skin tumors

Basal cell carcinoma, cutaneous mast cell tumor (often benign in cats, unlike the canine form), and squamous cell carcinoma on non-pigmented, sun-exposed sites (pinna, nasal planum, eyelids). Common in white outdoor cats.

Non-lymphoma nasal tumors

Adenocarcinoma, squamous cell carcinoma, fibrosarcoma. Distinguished from nasal lymphoma by biopsy under endoscopy.

Intracranial meningioma

The most common brain tumor in the senior cat. Often solitary, parasagittal, slow-growing. Good response rates to surgery when diagnosed before severe neurologic decline.

Diagnostic workup in cats

Recommended steps when cancer is suspected:

1. Detailed history: serial weights, appetite, vomiting, defecation, behavior.
2. Full physical exam with careful abdominal palpation, oral inspection, lymph node palpation.
3. CBC, chemistry panel, urinalysis.
4. FeLV/FIV testing if there is no prior result or more than a year has passed.
5. Abdominal ultrasound for masses, infiltration, mesenteric nodes.
6. Thoracic radiographs or CT to rule out pulmonary metastasis and a mediastinal mass.
7. Fine-needle aspiration cytology of any accessible mass or enlarged node.
8. Incisional or surgical biopsy when cytology is inconclusive.
9. Immunohistochemistry and PCR clonality for lymphoma when subtyping is needed.

Prognosis and quality of life

The owner's question is usually "how long does he have?" The responsible veterinary answer separates three axes:

• Expected survival by tumor type and stage.
• Quality of life during treatment (suffering, side effects, the quality of the days).
• The financial and emotional cost of the process.

Chemotherapy in cats is generally tolerated far better than in humans. Side effects are milder; in small-cell lymphoma, most cats eat, play, and keep a normal routine throughout treatment. That does not make the decision automatic, but it tempers the cultural prejudice that "chemotherapy means suffering." US owners weighing the cost should ask about veterinary financing options such as CareCredit, accepted at most specialty and AVMA-accredited practices.

What to remember

Three operational ideas for any owner of an adult cat.

First, small-cell intestinal lymphoma is the most common feline cancer today, it is mistaken for chronic IBD, and it responds well clinically when diagnosed. Any senior cat with a digestive picture lasting months deserves a workup that does not stop at "she's just getting old."

Second, spaying before one year of age prevents nearly nine of every ten mammary tumors in the queen. The number is decisive.

Third, the 3-2-1 rule (3 months, 2 cm, growing within 1 month) for any mass at an injection site is not optional. A week of delay in injection-site sarcoma turns surgery from curative into palliative.

Cancer is not a single disease, and a cat diagnosed with one feline tumor needs a workup matched to its type and stage. The common thread across these cancers is that the cats who do best are the ones whose owners brought a new symptom in early, before the tumor declared itself. Annual senior exams are where most of these are caught in time.